About
ViaNovaTx develops novel antiviral therapies targeting acute and subacute viral infections using advanced drug discovery methods to bring first-in-class treatments to the clinic.
Explore ViaNovaTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.